Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

European approval for Adartrel in RLS

April 11, 2006

Preclinical proof-of-concept for Myodur in DMD

April 11, 2006

TRO-19622: clinical candidate for motor neuron disease

April 11, 2006

Affiris closes EUR 8.5 million financing round

April 11, 2006

SUVN-501 elevates hippocampal levels of acetylcholine as a potential procognitive treatment

April 11, 2006

Interim phase I results reported for AAV-GAD gene therapy for Parkinson's disease

April 10, 2006

New PARG inhibitors for the treatment of Parkinson's disease identified

April 10, 2006

Pramipexole approved in Europe for restless legs syndrome

April 10, 2006

Daytrana approved for use in ADHD

April 10, 2006

ReNeuron to raise fund through international placing

April 10, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...